期刊文献+

Antioxidant Mechanism of Xiaojin Pill(小金丸) for Treatment of Peyronie’s Disease in Rats Based on Matrix Metalloproteinases 被引量:1

Antioxidant Mechanism of Xiaojin Pill(小金丸) for Treatment of Peyronie’s Disease in Rats Based on Matrix Metalloproteinases
原文传递
导出
摘要 Objective: To evaluate the effects of Xiaojin Pill(小金丸) in the treatment of Peyronie’s disease(PD) in a rat model. Methods: Twenty-four male Sprague-Dawley rats were randomly divided into four groups with 6 in each: sham operation, PD model, vehicle control and Xiaojin Pill groups. The rats in the sham operation group received penile tunica albsginea(TA) injection with 50 μL vehicle, while the rats in the other 3 groups received 50 μL penile TA injection of 50 μg transforming growth factor(TGF)-β1. Forty-two days after the injection, rats in the vehicle control and Xiaojin Pill groups received 0.5 mL water and Xiaojin Pill solution(107 mg/kg of body weight), respectively by gavage for 28 days, while those in the sham operation and PD model groups did not receive any intervention. After intervention, the expressions of matrix metalloproteinase 2/9(MMP2/9), nitric oxidesynthase(NOS), superoxide dismutase(SOD) and malondialdehyde(MDA) were measured. Results: Rats in the PD model and vehicle control groups presented obvious fibrosis in corpus cavernosum(CC) and demonstrated a significantly increased expressions of MMP2 and MMP9 in the CC compared with the sham operation group(all P<0.01). In contrast, the expressions of MMP2 and MMP9 in the Xiaojin Pill group were significantly down-regulated(both P<0.01). In addition, the levels of NOS and MDA in CC were significantly increased while the activity of SOD was decreased in the PD model and vehicle control groups compared with the sham operation group(al P<0.01). After Xiaojin Pil treatment, the levels of MDA, NOS and SOD appeared to be corrected(al P<0.01). Conclusions: Xiaojin Pill could reduce fibrosis in the CC by decreasing the expressions of MMPs, NOS and MDA, and by increasing the activity of SOD. Therefore, Xiaojin Pill might be a therapeutic option for PD. Objective: To evaluate the effects of Xiaojin Pill(小金丸) in the treatment of Peyronie’s disease(PD) in a rat model. Methods: Twenty-four male Sprague-Dawley rats were randomly divided into four groups with 6 in each: sham operation, PD model, vehicle control and Xiaojin Pill groups. The rats in the sham operation group received penile tunica albsginea(TA) injection with 50 μL vehicle, while the rats in the other 3 groups received 50 μL penile TA injection of 50 μg transforming growth factor(TGF)-β1. Forty-two days after the injection, rats in the vehicle control and Xiaojin Pill groups received 0.5 mL water and Xiaojin Pill solution(107 mg/kg of body weight), respectively by gavage for 28 days, while those in the sham operation and PD model groups did not receive any intervention. After intervention, the expressions of matrix metalloproteinase 2/9(MMP2/9), nitric oxidesynthase(NOS), superoxide dismutase(SOD) and malondialdehyde(MDA) were measured. Results: Rats in the PD model and vehicle control groups presented obvious fibrosis in corpus cavernosum(CC) and demonstrated a significantly increased expressions of MMP2 and MMP9 in the CC compared with the sham operation group(all P<0.01). In contrast, the expressions of MMP2 and MMP9 in the Xiaojin Pill group were significantly down-regulated(both P<0.01). In addition, the levels of NOS and MDA in CC were significantly increased while the activity of SOD was decreased in the PD model and vehicle control groups compared with the sham operation group(al P<0.01). After Xiaojin Pil treatment, the levels of MDA, NOS and SOD appeared to be corrected(al P<0.01). Conclusions: Xiaojin Pill could reduce fibrosis in the CC by decreasing the expressions of MMPs, NOS and MDA, and by increasing the activity of SOD. Therefore, Xiaojin Pill might be a therapeutic option for PD.
出处 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2019年第9期671-676,共6页 中国结合医学杂志(英文版)
基金 Supported by the China Postdoctoral Science Foundation(No.178641)
关键词 antioxidant mechanism Xiaojin PILL Chinese medicine Peyronie’s DISEASE RATS matrix METALLOPROTEINASES antioxidant mechanism Xiaojin Pill Chinese medicine Peyronie’s disease rats matrix metalloproteinases
  • 相关文献

参考文献3

二级参考文献59

  • 1张志辉,李旭平,杨侃.辛伐他汀对冠心病人丙二醛化低密度脂蛋白、妊娠相关蛋白酶-A的影响[J].中华高血压杂志,2007,15(2):110-114. 被引量:6
  • 2国际心脏病学会和协会及世界卫生组织临床命名标准化联合专题组.缺血性心脏病的命名及诊断标准[J].中华心血管病杂志,1981,9(2):75-75.
  • 3Behl C. Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches [ J ]. Prog Neurobiol, 1999,57:301 - 323.
  • 4Satoh T, Sakai N, Enokido Y, et al. Free radical independent protection by nerve growth factor and Bcl-2 of PC12 cells from hydrogen peroxide triggered-apoptosis [ J]. J Biochem, 1996,120:540 - 546.
  • 5Chander R, Rizvi F, Khanna AK, et al. Cardioprotective activity of synthetic guggulsterone ( E and Z isomers) in isoproterenol induced myocardial ischemia in rats: a comparative study [ J ]. Indian J Clin Biochem, 2003, 18:71 -79.
  • 6Meselhy MR. Inhibition of LPS-induced NO production by the oleogum resin of Commiphora wightii and its constituents [ J]. Phytochemistry, 2003,62:213 - 218.
  • 7Wang X, Greilberger J, Ledinski G, et al. The hypolipidemic natural product Commiphora mukul and its component guggulsterone inhibit oxidative modification of LDL [ J ]. Atherosclerosis, 2004,172:239 - 246.
  • 8Greene LA, Tischler AS. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor [ J ]. Proc Nat Acad Sci USA, 1976,73:2424 - 2428.
  • 9Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill [ J]. J Immunol Methods, 1989,119:203 - 210.
  • 10Green LC, Wagner DA, Glogowski J, et al. Analysis of nitrate,nitrite and [ 15N] nitrite in biological fluids [ J]. Anal Biochem, 1982,126 : 131 - 138.

共引文献50

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部